Advanced search
Publication Cover
Blood Pressure Volume 30, 2021 - Issue 1
Submit an article Journal homepage
2,810
Views
16
CrossRef citations to date
0
Altmetric
Editorial

Potential protective effects of antihypertensive treatments during the Covid-19 pandemic: from inhibitors of the renin-angiotensin system to beta-adrenergic receptor blockers

Sverre E. Kjeldsena Departments of Cardiology and Nephrology, University of Oslo, Ullevaal Hospital, Oslo, Norway;b Department of Nephrology, University of Oslo, Ullevaal Hospital, Oslo, NorwayCorrespondence[email protected]
,
Krzysztof Narkiewiczc Department of Hypertension and Diabetology, Medical University of Gdansk, Gdańsk, Poland
,
Michel Burnierd Service of Nephrology and Hypertension, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
&
Suzanne Oparile Vascular Biology and Hypertension Program, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
Pages 1-3 | Published online: 21 Dec 2020

Citations (16)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Mohamed A. Elrayess, Hadeel T. Zedan, Rand A. Alattar, Hatem Abusriwil, Mahmoud Khatib A. A. Al-Ruweidi, Shamma Almuraikhy, Jabeed Parengal, Bassem Alhariri, Hadi M. Yassine, Ali A. Hssain, Arun Nair, Musaed Al Samawi, Alaaeldin Abdelmajid, Jassim Al Suwaidi, Mohamed Omar Saad, Muna Al-Maslamani, Ali S. Omrani & Huseyin C. Yalcin. (2022) Soluble ACE2 and angiotensin II levels are modulated in hypertensive COVID-19 patients treated with different antihypertension drugs. Blood Pressure 31:1, pages 80-90.
Read now
Fabio Angeli, Paolo Verdecchia & Gianpaolo Reboldi. (2022) Pharmacotherapy for hypertensive urgency and emergency in COVID-19 patients. Expert Opinion on Pharmacotherapy 23:2, pages 235-242.
Read now
Maryam Khan, Guntaj Kaur Singh, Sakina Abrar, Roshan Ganeshan, Kara Morgan & Amer Harky. (2021) Pharmacotherapeutic agents for the management of COVID-19 patients with preexisting cardiovascular disease. Expert Opinion on Pharmacotherapy 22:18, pages 2455-2474.
Read now
Michel Burnier, Krzysztof Narkiewicz & Suzanne Oparil. (2021) Blood pressure target in patients with hypertension and type-2 diabetes older than 65 years. Is <130/80 mmHg the right target or an excessive objective preventing from achieving the clinical goals we are aiming at?. Blood Pressure 30:2, pages 79-81.
Read now

Articles from other publishers (12)

Adel E. Berbari, Najla A. Daouk & Edgar M. Nasr. 2023. Blood Pressure Disorders in Diabetes Mellitus. Blood Pressure Disorders in Diabetes Mellitus 3 17 .
Wiktoria Wojciechowska, Michał Terlecki, Marek Klocek, Agnieszka Pac, Agnieszka Olszanecka, Katarzyna Stolarz-SkrzypekMarek Jastrzębski, Piotr Jankowski, Aleksandra OstrowskaTomasz Drożdż, Aleksander Prejbisz, Piotr Dobrowolski, Andrzej JanuszewiczMarcin Krzanowski, Maciej T. MałeckiTomasz GrodzickiReinhold KreutzMarek Rajzer. (2022) Impact of Arterial Hypertension and Use of Antihypertensive Pharmacotherapy on Mortality in Patients Hospitalized due to COVID-19: The CRACoV-HHS Study. Hypertension 79:11, pages 2601-2610.
Crossref
Elpidio Santillo & Monica Migale. (2022) Beta receptor blocker therapy for the elderly in the COVID-19 era. World Journal of Clinical Cases 10:23, pages 8088-8096.
Crossref
Otavio Cabral-Marques, Gilad Halpert, Lena F. Schimke, Yuri Ostrinski, Aristo Vojdani, Gabriela Crispim Baiocchi, Paula Paccielli Freire, Igor Salerno Filgueiras, Israel Zyskind, Miriam T. Lattin, Florian Tran, Stefan Schreiber, Alexandre H. C. Marques, Desirée Rodrigues Plaça, Dennyson Leandro M. Fonseca, Jens Y. Humrich, Antje Müller, Lasse M. Giil, Hanna Graßhoff, Anja Schumann, Alexander Hackel, Juliane Junker, Carlotta Meyer, Hans D. Ochs, Yael Bublil Lavi, Carmen Scheibenbogen, Ralf Dechend, Igor Jurisica, Kai Schulze-Forster, Jonathan I. Silverberg, Howard Amital, Jason Zimmerman, Harry Heidecke, Avi Z. Rosenberg, Gabriela Riemekasten & Yehuda Shoenfeld. (2022) Autoantibodies targeting GPCRs and RAS-related molecules associate with COVID-19 severity. Nature Communications 13:1.
Crossref
Giovanna Gallo, Valentin Calvez & Carmine Savoia. (2022) Hypertension and COVID-19: Current Evidence and Perspectives. High Blood Pressure & Cardiovascular Prevention 29:2, pages 115-123.
Crossref
Farnoosh Nozari & Nasrin Hamidizadeh. (2022) The Effects of Different Classes of Antihypertensive Drugs on Patients with COVID-19 and Hypertension: A Mini-Review. International Journal of Hypertension 2022, pages 1-8.
Crossref
Fabio Angeli, Paolo Verdecchia, Antonella Balestrino, Claudio Bruschi, Piero Ceriana, Luca Chiovato, Laura Adelaide Dalla Vecchia, Francesco Fanfulla, Maria Teresa La Rovere, Francesca Perego, Simonetta Scalvini, Antonio Spanevello, Egidio Traversi, Dina Visca, Michele Vitacca & Tiziana Bachetti. (2022) Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry. Journal of Cardiovascular Development and Disease 9:1, pages 15.
Crossref
Giuseppe Mancia, Federico Rea, Guido Grassi, Sverre E. Kjeldsen, Reinhold Kreutz & Giovanni Corrao. 2022. Cardiovascular Complications of COVID-19. Cardiovascular Complications of COVID-19 303 316 .
O. A. Polyakova, O. D. Ostroumova, E. V. Mironova, N. M. Doldo, A. I. Listratov & A. V. Filippov. (2021) Prospects for the use of a fixed combination of bisoprolol and amlodipine in the treatment of patients with post-covid syndrome. Meditsinskiy sovet = Medical Council:14, pages 23-34.
Crossref
Anton Kondakov, Alexander Berdalin, Vladimir Lelyuk, Ilya Gubskiy & Denis Golovin. (2021) Risk Factors of In-Hospital Mortality in Non-Specialized Tertiary Center Repurposed for Medical Care to COVID-19 Patients in Russia. Diagnostics 11:9, pages 1687.
Crossref
Debmalya Barh, Alaa A. Aljabali, Murtaza M. Tambuwala, Sandeep Tiwari, Ángel Serrano-Aroca, Khalid J. Alzahrani, Bruno Silva Andrade, Vasco Azevedo, Nirmal Kumar Ganguly & Kenneth Lundstrom. (2021) Predicting COVID-19—Comorbidity Pathway Crosstalk-Based Targets and Drugs: Towards Personalized COVID-19 Management. Biomedicines 9:5, pages 556.
Crossref
Carmine Savoia, Massimo Volpe & Reinhold Kreutz. (2021) Hypertension, a Moving Target in COVID-19. Circulation Research 128:7, pages 1062-1079.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.